<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) accounts for approximately 15%-20% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0000726'>dementias</z:hpo>, but the relationship of progressive <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> to neurochemical changes is poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>We have therefore investigated glutamatergic synaptic markers in VaD </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We used homogenates prepared from gray matter from 2 neocortical regions (Brodmann area [BA] 9 and BA 20) and Western blotting to determine the concentrations of key components of the glutamatergic neurotransmitter system, vesicular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporter 1 (VGLUT1) and excitatory amino acid transporter EAAT2 (GLT-1), and the ubiquitous synaptic protein, synaptophysin, in 73 individuals-48 patients with cerebrovascular disease with and without <z:hpo ids='HP_0000726'>dementia</z:hpo>, 10 patients with AD, and 15 controls-in a case-control design </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: VGLUT1 concentrations in BA 20 and BA 9 were correlated with CAMCOG total (Rs 0.525, p = 0.018, n = 20; Rs 0.560, p = 0.002, n = 27) and CAMCOG memory scores (Rs 0.616, p = 0.004, n = 20; Rs 0.675, p = 0.000, n = 27) </plain></SENT>
<SENT sid="4" pm="."><plain>VGLUT1 concentration in BA 9 differed between the different <z:hpo ids='HP_0000726'>dementia</z:hpo> groups and the <z:hpo ids='HP_0001297'>stroke</z:hpo> no <z:hpo ids='HP_0000726'>dementia</z:hpo> group (1-way analysis of variance F = 6.69, p = 0.001 and Bonferroni p &lt; 0.01 in each case), with subjects with <z:hpo ids='HP_0001297'>stroke</z:hpo> who did not develop <z:hpo ids='HP_0000726'>dementia</z:hpo> exhibiting the highest mean value for VGLUT1 </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: These data suggest that loss of glutamatergic synapses is a feature of VaD and <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> but the preservation of synapses, in particular glutamatergic synapses, in the frontal cortex against the temporal cortex plays a role in sustaining cognition and protecting against <z:hpo ids='HP_0000726'>dementia</z:hpo> following a <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>